Protagenic Offering Tuesday, November 17, 2026 -0.40 Negative

Protagenic Therapeutics secures financing

Protagenic Therapeutics entered into a securities purchase agreement to sell to investors, thereby raising capital.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed